Delivery Order SPE2DB24D3013-SPE2DB25FFQNH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Topiramate 25 mg tablets in quantities of 500 units, with a ceiling value of $4,748.01 and an ultimate completion date of August 1, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,032.61 to AmerisourceBergen Drug Corp for 500 tablets of Topiramate 25 mg. The contract, which became effective on August 18, 2025, with an ultimate completion date of August 19, 2025, utilizes firm fixed price pricing and was awarded without a set-aside designation. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $5,076.43 to AmerisourceBergen Drug Corp for 500 tablets of Topiramate 25 mg, with an ultimate completion date of August 28, 2025. This competitive award, executed on August 27, 2025, utilizes firm fixed pricing and carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $7,564.11 to AmerisourceBergen Drug Corp for the supply of Topiramate 25 mg tablets in quantities of 500 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 15, 2025, and was awarded on September 12, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,789.72 for 500 tablets of Topiramate 25 mg, with a completion date of July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency has awarded a delivery order valued at $35,132.55 to AmerisourceBergen Drug Corp for the supply of Topiramate 25 mg tablets in quantities of 500 units. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of August 5, 2025, and represents a non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Topiramate 50 mg tablets in quantities of 1,000 units, valued at $2,393.22 with a firm fixed-price structure. This award represents a non-competed delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The contract will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $1,789.72 to AmerisourceBergen Drug Corp for the supply of Topiramate 25 mg tablets (500 count) with an ultimate completion date of August 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Topiramate 50 mg tablets in quantities of 1,000 units, with a contract ceiling value of $2,278.74 and an ultimate completion date of August 20, 2025. This is a firm fixed price, non-set-aside delivery order executed under a competitive procurement process. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Topiramate 50 mg tablets (1,000 count) with a ceiling value of $1,317.00. This firm fixed-price delivery order, which must be completed by September 2, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The contract carries no set-aside designation, indicating it was competitively awarded through open procurement channels. This...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFQNHDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of 500 tablets of Topiramate 25 mg at a ceiling value of $8,738.79. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. The contract is set for completion by September 15, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. Topiramate is a generic anticonvulsant medication commonly used in military and veteran healthcare settings for seizure management and other neurological conditions. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen maintains an extensive portfolio of medications and medical supplies serving the Defense Health Agency and other government healthcare systems. This delivery order represents one of numerous competitively awarded contracts through which the company fulfills federal pharmaceutical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.7k | 9/12/25 |